| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |